His main research concerns Immunology, Cancer, Antigen, Immunotherapy and Vaccination. His Immunology research is multidisciplinary, incorporating perspectives in Peripheral blood mononuclear cell and Internal medicine, Clinical trial. His Clinical trial study incorporates themes from Human leukocyte antigen and Oncology.
His Antigen research incorporates themes from Viral Vaccine and Chickenpox. The study incorporates disciplines such as Epitope, Prostate cancer and Combination therapy in addition to Immunotherapy. His studies in Vaccination integrate themes in fields like Cancer vaccine and Lung cancer.
His scientific interests lie mostly in Immunology, Internal medicine, Cancer, Vaccination and Oncology. As part of his studies on Immunology, Akira Yamada often connects relevant areas like Cytotoxic T cell. In Cytotoxic T cell, Akira Yamada works on issues like Human leukocyte antigen, which are connected to Virology and Hepatitis C virus.
His study focuses on the intersection of Vaccination and fields such as Adverse effect with connections in the field of Randomized controlled trial. His Antigen research includes themes of Molecular biology, Antibody and Adenocarcinoma. The concepts of his Immunotherapy study are interwoven with issues in Peripheral blood mononuclear cell and Combination therapy.
His primary areas of study are Internal medicine, Oncology, Vaccination, Cancer and Immunology. Akira Yamada has researched Internal medicine in several fields, including Gastroenterology and Peptide vaccine. His Oncology research incorporates elements of Survival analysis, Randomized controlled trial, Prostate cancer and Chemotherapy.
His work carried out in the field of Vaccination brings together such families of science as Adverse effect and Immune system. His work deals with themes such as Biomarker and Hazard ratio, which intersect with Cancer. His studies deal with areas such as Colorectal cancer and HMGB1 as well as Immunology.
Akira Yamada mostly deals with Internal medicine, Vaccination, Immunology, Oncology and Immune system. As part of the same scientific family, he usually focuses on Internal medicine, concentrating on Gastroenterology and intersecting with Hazard ratio. His Vaccination research is multidisciplinary, relying on both Cancer vaccine, Adverse effect, Antigen and Peptide vaccine.
Akira Yamada has included themes like Cancer, Immunotherapy, Hepatitis C and Hepatitis C virus in his Antigen study. His study looks at the relationship between Immunology and fields such as Survival analysis, as well as how they intersect with chemical problems. His Oncology study integrates concerns from other disciplines, such as Survival rate, Randomized controlled trial and Chemotherapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Multifunctional Alloys Obtained via a Dislocation-Free Plastic Deformation Mechanism.
Takashi Saito;Tadahiko Furuta;Jung-Hwan Hwang;Shigeru Kuramoto.
Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese.
T. Higuchi;N. Seki;S. Kamizono;A. Yamada.
Tissue Antigens (1998)
Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome.
Yukiko Ohyama;Seiji Nakamura;Goro Matsuzaki;Masanori Shinohara.
Arthritis & Rheumatism (1996)
Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL.
Masanobu Nakao;Shigeki Shichijo;Toshihiro Imaizumi;Yoshiko Inoue.
Journal of Immunology (2000)
Next‐generation peptide vaccines for advanced cancer
Akira Yamada;Tetsuro Sasada;Masanori Noguchi;Kyogo Itoh.
Cancer Science (2013)
Immunologic Evaluation of Personalized Peptide Vaccination for Patients with Advanced Malignant Glioma
Naoki Yajima;Ryuya Yamanaka;Takashi Mine;Naoto Tsuchiya.
Clinical Cancer Research (2005)
Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination.
Masanori Noguchi;Kazuhiko Kobayashi;Norie Suetsugu;Katsurou Tomiyasu.
The Prostate (2003)
Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses.
Takashi Mine;Yuji Sato;Masanori Noguchi;Teruo Sasatomi.
Clinical Cancer Research (2004)
Induction of Cellular Immune Responses to Tumor Cells and Peptides in Colorectal Cancer Patients by Vaccination with SART3 Peptides
Yoshiaki Miyagi;Nobue Imai;Teruo Sasatomi;Akira Yamada.
Clinical Cancer Research (2001)
Diagnostic skin test reactions with varicella virus antigen and clinical application of the test.
Hitoshi Kamiya;Toshiaki Ihara;Akihiko Hattori;Toshiaki Iwasa.
The Journal of Infectious Diseases (1977)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: